Unternehmen | Analyst | Empfehlung | Target price of Shares listed at Frankfurt Stock Exchange (in EUR) | Target Price of ADS listed at NASDAQ New York (in USD) | Datum of latest Research Report |
BofA | Derik de Bruin | UNDERPERFORM | 4.50 D | 22 May 2024 | |
Bryan Garnier & Co | Alex Cogut | BUY | 22.00 € | - | 29 September 2022 |
Citigroup Inc. | Peter Verdult | BUY | 30.00 € | - | 22 May 2024 |
TD Cowen | Steven Mah | BUY | - | 19.00 D | 27 June 2024 |
Deutsche Bank | Falko Friedrichs | BUY | 12.00 € | - | 22 May 2024 |
H.C. Wainwright & Co. | Douglas Tsao | BUY | - | 14.00 D | 31 August 2023 |
IntronHealth | Naresh Chouhan | SELL | 7.35 € | 17 June 2024 | |
Jefferies | Peter Welford | BUY | 16.00 € | - | 22 May 2024 |
Morgan Stanley | James Quigley | OVERWEIGHT | 28.00 € | - | 22 May 2024 |
ODDO BHF | Stephan Wulf | OUTPERFORM | 13.50 € | - | 22 May 2024 |
Royal Bank of Canada (RBC) | Zoe Karamanoli | OUTPERFOM | 16.00 € | - | 10 June 2024 |
Rx Securities | Dr Samir Devani | BUY | 20.00 € | - | 12 June 2024 |
Van Lanschot Kempen | Sebastiaan van der Schoot | BUY | 15.00 € | - | 07 May 2024 |
Warburg Research | Dr Christian Ehmann | BUY | 18.00 € | - | 22 May 2024 |
Average target price | 17.95 € | 12.50 D |